Trimeris
Manufacturing · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3500 Paramount Pkwy, Morrisville, North ...Phone Number
(919) 419-6050Website
www.trimeris.comRevenue
$25 MillionIndustry
ZI Rank: 1
About Trimeris
Trimeris Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trimeris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Trimeris has new funding data
Click to see if Trimeris had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Trimeris recently announced quarterly report
Check out if Trimeris is spiking on competitors!
Check if Trimeris has recently received funding, and reach out quickly before it becomes old news!
Trimeris, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Trimeris launches new products
Congratulate Masked Content for being promoted to Masked Content at Trimeris
Recommended Actions
Reach out to Masked Content who joined Trimeris as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Trimeris is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Trimeris is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Trimeris.
Trimeris Tech Stack
A closer look at the technologies used by Trimeris
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trimeris
Trimeris, Inc. (NASDAQ: TRMS) pioneered the development of a class of antiviral drug treatments called fusion inhibitors. The Company's currently marketed product is FUZEON, an anti-HIV fusion inhibitor which was developed by the Company in collaboration with Roche. Substantially all of Trimeris' revenues are derived from the Company's collaboratio... Read More
